UBU5:XETRA:XETRA-UBS (Irl) plc - MSCI USA Value UCITS USD A-dis (EUR)

ETF | Others |

Last Closing

USD 106.58

Change

-0.70 (-0.65)%

Market Cap

USD 0.63B

Volume

3.38K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.66%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.24 (-0.88%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.27 (-0.95%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.36%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-1.08 (-0.76%)

USD 102.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.66 (-1.44%)

USD 101.20B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.65%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.24 (-0.23%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.62 (-0.27%)

USD 80.38B

ETFs Containing UBU5:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.83% 71% C- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.83% 70% C- 71% C-
Trailing 12 Months  
Capital Gain 18.26% 70% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.26% 70% C- 70% C-
Trailing 5 Years  
Capital Gain 40.38% 70% C- 71% C-
Dividend Return 8.34% 51% F 38% F
Total Return 48.72% 73% C 72% C
Average Annual (5 Year Horizon)  
Capital Gain 12.13% 74% C 72% C
Dividend Return 12.13% 73% C 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.95% 44% F 54% F
Risk Adjusted Return 86.98% 79% B- 82% B
Market Capitalization 0.63B 69% C- 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.